Cyanvac

0 followers

‌

Cyanvac develops vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector.

Industries

Headquarters

Links

Org chart

Chief Executive Officer

Fred C. Davison

Collapse

Chief Financial Officer

Chief Scientific Officer

Chief Regulatory Officer

Chief Business Officer

This company has no teams yet

Merck

230 followers

AbbVie

201 followers

Pfizer

523 followers

Amgen

234 followers

Revvity

7 followers

Aurobindo Pharma USA, Inc.

2 followers

Truepill

5 followers

Bristol-Myers Squibb

207 followers

UC Health

3 followers

Thermo Fisher Scientific

179 followers

Genentech

161 followers

Explore companies